Learning Objectives

Upon completion of the educational activity, participants should be able to:

Keynote Session - Equity in Focus: Lifecourse Trajectories and System-Level Gaps in Pediatric Rheumatology

• Apply guideline-directed, evidence-based treatment and management strategies to complex rheumatic disease to achieve optimal outcomes
• Assess the impact of multisystem involvement, overlapping conditions, and comorbidities (such as obesity) on rheumatic disease course, treatment, outcomes
• Integrate patient-reported outcomes, quality-of-life and disease burden measures, and social determinants of health into longitudinal, patient-centered care
• Implement interprofessional, team-based care to improve coordination, access, and long-term outcomes for patients with complex rheumatic diseases

Improving Outcomes in SLE and LN: Integrating New Guidelines and Evolving Treatments

• Differentiate the immuno-inflammatory pathways and autoantibodies that drive distinct disease phenotypes, and use them to individualize therapy
• Interpret clinical, serologic, imaging, and biomarker findings to improve rheumatic disease diagnosis, classification, early detection, and risk stratification
• Evaluate conventional, targeted, and emerging therapies for rheumatic diseases and comorbidities by mechanism, efficacy, safety, guidelines, and patient eligibility to guide treatment decisions
• Apply guideline-directed, evidence-based treatment and management strategies to complex rheumatic disease to achieve optimal outcomes
• Assess the impact of multisystem involvement, overlapping conditions, and comorbidities (such as obesity) on rheumatic disease course, treatment, outcomes
• Integrate patient-reported outcomes, quality-of-life and disease burden measures, and social determinants of health into longitudinal, patient-centered care

Closing Gaps in Idiopathic Inflammatory Myopathies: Advancing Evidence-Based Diagnosis and Evolving Therapeutic Strategies

• Differentiate the heterogeneous clinical presentations, systemic manifestations, comorbidities, and patient burden of idiopathic inflammatory myopathies (IIMs)
• Integrate evidence-based diagnostic tools, autoantibody profiles, and prognostic biomarkers to improve IIM diagnosis, classification, and treatment
• Explain the role of immune pathways and autoantibodies in shaping IMM disease pathophysiology and clinical phenotypes
• Evaluate current and emerging therapeutic options for IIMs based on mechanisms of action, safety profiles, efficacy data, and indications
• Implement multidisciplinary, patient-centered strategies to optimize coordinated diagnosis, treatment, and long-term management of IIMs

Commercial Support

This session is supported from an independent medical education grant from Argenx and Priovant.

Leadership Session - Nerve to Lead: Confronting Inequity and Redefining Leadership in Rheumatology

• Analyze key drivers of gender inequities in workforce advancement, including structural, cultural, and intersectional factors
• Identify how bias and inequities manifest in compensation, promotion, leadership selection, and research opportunities
• Evaluate the impact of workforce inequities on organizational performance, workforce sustainability, and patient outcomes
• Apply practical leadership strategies to address inequities, including implementation of equity metrics, sponsorship models, and policy-level interventions
• Develop actionable approaches to foster inclusive, equitable workplace environments that support retention, advancement, and leadership diversity

Commercial Support

This session is supported from an independent medical education grant from Johnson & Johnson.

A New Era in Sjögren’s Care: Redefining Patient Burden, Recognizing Multi-Organ Involvement, and Advancing Emerging Therapies

• Recognize the diverse clinical spectrum and multi-organ burden of Sjögren’s disease (SjD) and its impact on patient quality of life
• Describe the immuno-inflammatory mechanisms driving SjD and their relevance to emerging therapeutic targets
• Evaluate emerging therapies for SjD based on mechanisms of action, safety, and efficacy data, and patient eligibility
• Apply guideline-directed, multidisciplinary strategies to develop personalized, patient-centered management plans for individuals with SjD

Commercial Support

This session is supported from an independent medical education grant from Novartis.

Bridging the Spectrum of SpA and IBD: Immune Overlap, Disease Convergence, and Clinical Crossroads

• Interpret clinical, serologic, imaging, and biomarker findings to improve rheumatic disease diagnosis, classification, early detection, and risk stratification
• Evaluate conventional, targeted, and emerging therapies for rheumatic diseases and comorbidities by mechanism, efficacy, safety, guidelines, and patient eligibility to guide treatment decisions
• Apply guideline-directed, evidence-based treatment and management strategies to complex rheumatic disease to achieve optimal outcomes
• Assess the impact of multisystem involvement, overlapping conditions, and comorbidities (such as obesity) on rheumatic disease course, treatment, outcomes
• Integrate patient-reported outcomes, quality-of-life and disease burden measures, and social determinants of health into longitudinal, patient-centered care
• Implement interprofessional, team-based care to improve coordination, access, and long-term outcomes for patients with complex rheumatic diseases

Obesity and PsA: New Evidence for an Integrated Treatment Approach and Better Patient Outcomes

• Characterize the cumulative clinical burden of psoriatic arthritis and obesity, including their bidirectional impact on inflammation and disease severity
• Evaluate evidence demonstrating how obesity influences PsA disease measures and treatment response, with emphasis on key trials of integrated treatment approaches
• Analyze emerging evidence to construct a comprehensive, patient-centered care framework that advances care for patients with PsA and obesity

Commercial Support

This session is supported from an independent medical education grant from Lilly.

Spotlight Session - Practical AI in Rheumatology: Adoption, Validation, and Safeguards in Clinical Practice

• Interpret clinical, serologic, imaging, and biomarker findings to improve rheumatic disease diagnosis, classification, early detection, and risk stratification
• Apply guideline-directed, evidence-based treatment and management strategies to complex rheumatic disease to achieve optimal outcomes
• Integrate patient-reported outcomes, quality-of-life and disease burden measures, and social determinants of health into longitudinal, patient-centered care
• Implement interprofessional, team-based care to improve coordination, access, and long-term outcomes for patients with complex rheumatic diseases

Fellows Podium Presentation: Key Abstracts on Original Research and Case Studies

• Apply guideline-directed, evidence-based treatment and management strategies to complex rheumatic disease to achieve optimal outcomes
• Assess the impact of multisystem involvement, overlapping conditions, and comorbidities (such as obesity) on rheumatic disease course, treatment, outcomes
• Integrate patient-reported outcomes, quality-of-life and disease burden measures, and social determinants of health into longitudinal, patient-centered care
• Implement interprofessional, team-based care to improve coordination, access, and long-term outcomes for patients with complex rheumatic diseases

Workshop: Ultrasound Imaging Techniques (Hands-on)

• Interpret clinical, serologic, imaging, and biomarker findings to improve rheumatic disease diagnosis, classification, early detection, and risk stratification
• Apply guideline-directed, evidence-based treatment and management strategies to complex rheumatic disease to achieve optimal outcomes
• Implement interprofessional, team-based care to improve coordination, access, and long-term outcomes for patients with complex rheumatic diseases

Workshop: Legal Hot Topics for Rheumatologists

• Implement interprofessional, team-based care to improve coordination, access, and long-term outcomes for patients with complex rheumatic diseases

Workshop: Virtual & Remote Care in Rheumatology Practice

• Apply guideline-directed, evidence-based treatment and management strategies to complex rheumatic disease to achieve optimal outcomes
• Integrate patient-reported outcomes, quality-of-life and disease burden measures, and social determinants of health into longitudinal, patient-centered care
• Implement interprofessional, team-based care to improve coordination, access, and long-term outcomes for patients with complex rheumatic diseases

Workshop: Clinical Research in Private Practice

• Interpret clinical, serologic, imaging, and biomarker findings to improve rheumatic disease diagnosis, classification, early detection, and risk stratification
• Evaluate conventional, targeted, and emerging therapies for rheumatic diseases and comorbidities by mechanism, efficacy, safety, guidelines, and patient eligibility to guide treatment decisions
• Apply guideline-directed, evidence-based treatment and management strategies to complex rheumatic disease to achieve optimal outcomes
• Implement interprofessional, team-based care to improve coordination, access, and long-term outcomes for patients with complex rheumatic diseases.

Workshop: Physics of Vision in Burnout & Leadership

• Analyze the structural, cultural, and intersectional drivers of workforce inequity (including gender bias in pay, promotion, and leadership) and its impact on rheumatology practices, organizations, and patients
• Apply leadership strategies (equity metrics, sponsorship, and policy interventions) to build an inclusive rheumatology workforce that support retention, advancement, and diversity

Workshop: Narrative Medicine in Pediatric Rheumatology

• Apply guideline-directed, evidence-based treatment and management strategies to complex rheumatic disease to achieve optimal outcomes
• Assess the impact of multisystem involvement, overlapping conditions, and comorbidities (such as obesity) on rheumatic disease course, treatment, outcomes
• Integrate patient-reported outcomes, quality-of-life and disease burden measures, and social determinants of health into longitudinal, patient-centered care
• Implement interprofessional, team-based care to improve coordination, access, and long-term outcomes for patients with complex rheumatic diseases

Workshop: APP Workforce and Compensation

• Analyze the structural, cultural, and intersectional drivers of workforce inequity (including gender bias in pay, promotion, and leadership) and its impact on rheumatology practices, organizations, and patients
• Apply leadership strategies (equity metrics, sponsorship, and policy interventions) to build an inclusive rheumatology workforce that support retention, advancement, and diversity

Workshop: Career Paths and Opportunities for Early-Stage Trainees

• Analyze the structural, cultural, and intersectional drivers of workforce inequity (including gender bias in pay, promotion, and leadership) and its impact on rheumatology practices, organizations, and patients
• Apply leadership strategies (equity metrics, sponsorship, and policy interventions) to build an inclusive rheumatology workforce that support retention, advancement, and diversity

Workshop: Career Paths and Opportunities for Fellows and Late-Stage Trainees

• Analyze the structural, cultural, and intersectional drivers of workforce inequity (including gender bias in pay, promotion, and leadership) and its impact on rheumatology practices, organizations, and patients
• Apply leadership strategies (equity metrics, sponsorship, and policy interventions) to build an inclusive rheumatology workforce that support retention, advancement, and diversity